Inhibition of Cathepsin K Activity and the treatment and prevention of disease

Details for Australian Patent Application No. 2006222712 (hide)

Owner Sylvan Pharmaceuticals Pty Ltd

Inventors Little, Christopher Bond; Cullis-Hill, David; Hannon, Robert Logan; Smith, Margaret Mary

Agent FB Rice

Pub. Number AU-A-2006222712

Filing date 27 September 2006

Wipo publication date 10 April 2008

International Classifications

A61K 31/737 (2006.01) - Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 19/08 (2006.01) Drugs for skeletal disorders

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/04 (2006.01) Antineoplastic agents

Event Publications

19 October 2006 Complete Application Filed

10 April 2008 Application Open to Public Inspection

  Published as AU-A-2006222712

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006222713-Electronic conference system, electronic conference controller, information terminal device, and electronic conference support method

2006222711-Crystalline pharmaceutical